<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02805517</url>
  </required_header>
  <id_info>
    <org_study_id>5160152</org_study_id>
    <nct_id>NCT02805517</nct_id>
  </id_info>
  <brief_title>Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Donor Nephrectomy</brief_title>
  <official_title>A Prospective Study of Port Site Pain Following Percutaneous Externally-Assembled Laparoscopic Donor Nephrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a single-arm prospective internally-controlled study. Patients will undergo&#xD;
      percutaneous externally-assembled laparoscopic donor nephrectomy where one or more 3 mm&#xD;
      instruments are added or substituted for conventional 5 or 10 mm trocars. Multiple outcome&#xD;
      measures (endpoints) will be measured including time to first opioid use, total inpatient&#xD;
      opioid dosage, patient ranking of painfulness of each port site, duration of ileus, time to&#xD;
      ambulation, length of hospital stay, presence of any intraoperative or postoperative&#xD;
      complications, operating time, estimated blood loss, and other routine parameters collected&#xD;
      in a prospective surgical study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose:&#xD;
&#xD;
      Prior investigators have created methods to perform laparoscopic surgeries using smaller&#xD;
      instruments and ports in an attempt to improve cosmesis and postoperative pain. However,&#xD;
      These methods may be limited by the requirement for smaller instruments with decreased&#xD;
      functionality or by the loss of instrument triangulation. We have previously published a&#xD;
      study regarding the use of a new surgical paradigm (percutaneous externally assembled&#xD;
      laparoscopy, or PEAL) in porcine and cadaveric models in order to allow laparoscopic surgery&#xD;
      to take place with improved cosmesis and decreased pain while still allowing the use of&#xD;
      larger instruments and maintaining instrument triangulation. We now seek to study the use of&#xD;
      these instruments in the human patients undergoing laparoscopic urologic surgery.&#xD;
&#xD;
      The procedures include:&#xD;
&#xD;
      Hundred subjects will be recruited for the study with an expected attrition rate of 10%.&#xD;
      Sample size has been minimized, but is necessary for statistical power and conclusions.&#xD;
      Subjects will be male and female 18 years or older, of all ethnicities, denominations or&#xD;
      other social/economical variations. All participants will speak English fluently in order for&#xD;
      consent to be performed properly. Baseline pain score will be calculated through a&#xD;
      questionnaire in at the urology clinic&#xD;
&#xD;
      This will be a single-arm prospective internally-controlled study. Patients will undergo&#xD;
      percutaneous externally-assembled laparoscopic urologic surgery where one or more 3 mm&#xD;
      instruments are added or substituted for conventional 5 or 10 mm trocars. Multiple outcome&#xD;
      measures (endpoints) will be measured including time to first opioid use, total inpatient&#xD;
      opioid dosage, patient ranking of painfulness of each port site, duration of ileus, time to&#xD;
      ambulation, length of hospital stay, presence of any intraoperative or postoperative&#xD;
      complications, operating time, estimated blood loss, and other routine parameters collected&#xD;
      in a prospective surgical study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Number of kidney donors decreased, not able to enroll subjects at this time&#xD;
  </why_stopped>
  <start_date type="Actual">July 11, 2016</start_date>
  <completion_date type="Actual">May 26, 2021</completion_date>
  <primary_completion_date type="Actual">May 26, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first opioid use</measure>
    <time_frame>up to 30 days postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total inpatient opioid dosage</measure>
    <time_frame>30 days postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score of all surgical sites</measure>
    <time_frame>up to 3 days postoperatively</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Laparoscopic Donor Nephrectomy</condition>
  <arm_group>
    <arm_group_label>PEAL laparoscopic nephrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo percutaneous externally-assembled laparoscopic donor nephrectomy using 3 mm instruments.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percuvanceâ„¢ Percutaneous Surgical System</intervention_name>
    <description>Patients will undergo percutaneous externally-assembled laparoscopic donor nephrectomy where one or more 3 mm instruments are added or substituted for conventional 5 or 10 mm trocars.</description>
    <arm_group_label>PEAL laparoscopic nephrectomy</arm_group_label>
    <other_name>PERCUTANEOUS EXTERNALLY-ASSEMBLED LAPAROSCOPIC (PEAL)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing laparoscopic donor nephrectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unwilling to participate in the study&#xD;
&#xD;
          -  Patients unfit for laparoscopic surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Keheila, MD</last_name>
    <role>Study Director</role>
    <affiliation>Loma Linda University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Arenas JL, Alsyouf M, Jang M, Myklak K, Faaborg D, Khater N, Baldwin DD. Percutaneous Externally Assembled Laparoscopic Instruments: Creation of a New Surgical Paradigm. J Endourol. 2016 Apr;30(4):433-40. doi: 10.1089/end.2015.0240. Epub 2016 Feb 9.</citation>
    <PMID>26732739</PMID>
  </reference>
  <reference>
    <citation>Rossitto C, Gueli Alletti S, Costantini B, Fanfani F, Scambia G. Total Laparoscopic Hysterectomy With Percutaneous (Percuvance) Instruments: New Frontier of Minimally Invasive Gynecological Surgery. J Minim Invasive Gynecol. 2016 Jan;23(1):14-5. doi: 10.1016/j.jmig.2015.09.004. Epub 2015 Sep 18.</citation>
    <PMID>26386388</PMID>
  </reference>
  <reference>
    <citation>Chang J, Boules M, Rodriguez J, Kroh M. Minilaparoscopy with Interchangeable, Full 5-mm End Effectors: First Human Use of a New Minimally Invasive Operating Platform. J Laparoendosc Adv Surg Tech A. 2016 Jan;26(1):1-5. doi: 10.1089/lap.2015.0418. Epub 2015 Nov 30.</citation>
    <PMID>26618278</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 14, 2016</study_first_submitted>
  <study_first_submitted_qc>June 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2016</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Minimally Invasive Surgical Procedures</keyword>
  <keyword>Transplant Donors</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

